Conference agenda

Programme for the Anglonordic Biotech Conference IX, 2012

23 May

Kick-off!
The conference starts with a reception at the Residence of the Swedish Ambassador in London the evening before the event. The reception starts at 18.30 and ends 20.00.
Please note that there is a separate registration for the reception and a limited number of 150 participants at the Residence (registration closes when fully booked).

(Please note that there is a separate registration for the drink reception)

24 May

09.00 – 09.40 Registration at 1VS Westminster Conference Centre, 1 Victoria Street, London, SW1

09.40 – 09.50

Welcome Remarks from the Conference Chairman – Ole Jørgen Marvik, Sector Head, Health and Life Sciences, Innovation Norway

09.50 – 10.30 Partnering pitches
ProtAffin - www.protaffin.com
Creative Antibiotics - www.creativeantibiotics.com
EpiTherapeutics - www.epitherapeutics.dk 

10.30 – 11.00

Topic to be confirmed – Rob Pinnock, Director, External Scientific Affairs & Alliance Management UK, Ireland, Portugal & Spain, Worldwide Licensing, MSD

11.00 – 11.30  

BIOTECHNOLOGY: The Challenges of the Future - Keynote speaker – Baroness Susan Greenfield

11.30 – 12.00 

What is the evidence that rationale selection of patients is improving patient outcomes – Nexus Oncology, Clare Wareing, Founder and CSO

12.00 – 13.20 LUNCH - sponsored by Ezenze

13.20 – 14.05

If I Knew Then What I Know Today (Panel)
Moderator:
Mike Ward, Editor-in-Chief, Scrip Intelligence
Panel:
  - Sir Greg Winter
 - Leif Helth Jensen, Investment Manager, CAT Management
 - Tom Pike, Chairman/Director, Vaccibody AS, Clanotech AB, Diagenic
   ASA and others

14.05 – 14.55 

Partnering pitches
F-star - www.f-star.com
Orexo - www.orexo.com
Novozymes Biopharma - www.biopharma.novozymes.com
Xention - www.xention.com

14.55 – 15.25 

The value and scope of biotech patents - the misconceptions and the reality - Elizabeth Jones, Partner, Dehns

15.25 – 15.45

Partnership and collaborations in translational research: New models from the UK - Matthew Hallsworth, Head of External Relations, NIHR Office for Clinical Research Infrastructure

15.45 – 16.00

Translational research and clinical trials in Denmark:Excellence in early drug development - Lars Arendt-Nielsen, Director of R&D, C4Pain & Head of Centre and Professor, Aalborg University

16.00 – 16.30

Latest News on European Funding – Dinko Valerio, Partner and Co-founder, Aescap Venture

16.30 – 16.45 Conclusions and Q&A
16.45 – 18.30  Afternoon Buffet and Drinks - sponsored by Enzenze